Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-experienced people with challenges using currently available regimens, high pill burdens, and reduced adherence. Listen on the go or follow along with our expert-curated slides. Topics covered include: Current Options for Simplifying ART DHHS and EACS Recommendations for 2-Drug Regimens The Latest Results of the ARTISTRY-1 and -2 Trials Future Directions for HIV Therapy Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of Infection and Inequities Dean for Healthcare Transformation Faculty of Medicine and Dentistry Queen Mary University of London Honorary Consultant Physician Barts Health NHS Trust London, United Kingdom Jihad Slim, MD Assistant Professor of Medicine New York Medical College Valhalla, New York Chief of Infectious Disease Saint Michael’s Medical Center Newark, New Jersey Link to program page: https://bit.ly/4u31NGv Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related